Clearing a way through the CRISPR patent jungle – Life Sciences Intellectual Property Review
Life Sciences Intellectual Property Review |
Clearing a way through the CRISPR patent jungle
Life Sciences Intellectual Property Review The revocation of the Broad Institute's patent EP2771468, reported and discussed here, marks the latest major development in a series of patent battles over the revolutionary and highly lucrative CRISPR/Cas 9 technology (and other gene-editing … |
